ATE273304T1 - (s)-4-amino-5-chloro-2-methoxy-n-(1-(1-(2- tetrahydrofuryl-carbonyl)-4-piperidinylmethyl)- - piperidinyl)benzamid zur behandlung von magen- darmbewegungskrankheiten - Google Patents
(s)-4-amino-5-chloro-2-methoxy-n-(1-(1-(2- tetrahydrofuryl-carbonyl)-4-piperidinylmethyl)- - piperidinyl)benzamid zur behandlung von magen- darmbewegungskrankheitenInfo
- Publication number
- ATE273304T1 ATE273304T1 AT03250050T AT03250050T ATE273304T1 AT E273304 T1 ATE273304 T1 AT E273304T1 AT 03250050 T AT03250050 T AT 03250050T AT 03250050 T AT03250050 T AT 03250050T AT E273304 T1 ATE273304 T1 AT E273304T1
- Authority
- AT
- Austria
- Prior art keywords
- piperidinyl
- tetrahydrofuryl
- benzamide
- carbonyl
- chloro
- Prior art date
Links
- -1 (S)-4-AMINO-5-CHLORO-2-METHOXY-N-(1-(1-(2- TETRAHYDROFURYL-CARBONYL)-4-PIPERIDINYL METHYL)- - PIPERIDINYL)BENZAMIDE Chemical compound 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002141262 | 2002-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE273304T1 true ATE273304T1 (de) | 2004-08-15 |
Family
ID=29267809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03250050T ATE273304T1 (de) | 2002-05-16 | 2003-01-03 | (s)-4-amino-5-chloro-2-methoxy-n-(1-(1-(2- tetrahydrofuryl-carbonyl)-4-piperidinylmethyl)- - piperidinyl)benzamid zur behandlung von magen- darmbewegungskrankheiten |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6696468B2 (de) |
| EP (1) | EP1362857B1 (de) |
| JP (1) | JP3643107B2 (de) |
| KR (1) | KR20040107520A (de) |
| CN (1) | CN1653063A (de) |
| AR (1) | AR040021A1 (de) |
| AT (1) | ATE273304T1 (de) |
| AU (1) | AU2003230245A1 (de) |
| BR (1) | BR0309933A (de) |
| CA (1) | CA2483368A1 (de) |
| CZ (1) | CZ20041084A3 (de) |
| DE (1) | DE60300021T2 (de) |
| DK (1) | DK1362857T3 (de) |
| ES (1) | ES2227500T3 (de) |
| HU (1) | HUP0501016A2 (de) |
| IL (1) | IL165012A0 (de) |
| MX (1) | MXPA04011332A (de) |
| NO (1) | NO20045469L (de) |
| PL (1) | PL372724A1 (de) |
| PT (1) | PT1362857E (de) |
| RU (1) | RU2004136853A (de) |
| SK (1) | SK50192004A3 (de) |
| TR (1) | TR200403020T2 (de) |
| TW (1) | TW200400186A (de) |
| WO (1) | WO2003097638A1 (de) |
| ZA (1) | ZA200409053B (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904377D0 (sv) * | 1999-12-01 | 1999-12-01 | Astra Pharma Prod | Pharmaceutical combinations |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| ATE441646T1 (de) * | 2004-11-05 | 2009-09-15 | Theravance Inc | 5-ht4-rezeptoragonistenverbindungen |
| EP1807423B1 (de) * | 2004-11-05 | 2009-05-20 | Theravance, Inc. | Chinolinon-carboxamid-verbindungen |
| ATE469897T1 (de) * | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
| NZ560828A (en) * | 2005-03-02 | 2011-01-28 | Theravance Inc | Quinolinone compounds as 5-HT4 receptor agonists |
| MY147756A (en) | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| US7256294B2 (en) * | 2005-05-25 | 2007-08-14 | Theravance, Inc. | Crystalline form of a benzimidazole-carboxamide medicinal compound |
| EP1888527A1 (de) * | 2005-05-27 | 2008-02-20 | AstraZeneca AB | Piperidine zur behandlung von chemokinvermittelten krankheiten |
| TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
| JP2009501793A (ja) | 2005-07-21 | 2009-01-22 | アストラゼネカ・アクチエボラーグ | 新規ピペリジン誘導体 |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| TWI423967B (zh) * | 2008-02-21 | 2014-01-21 | Dainippon Sumitomo Pharma Co | 醯胺衍生物及含有其之醫藥組合物 |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| JP2013518085A (ja) | 2010-02-01 | 2013-05-20 | ノバルティス アーゲー | ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体 |
| JP5748777B2 (ja) | 2010-02-02 | 2015-07-15 | ノバルティス アーゲー | Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体 |
| UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
| CA2867043A1 (en) | 2012-05-03 | 2013-11-07 | Novartis Ag | L-malate salt of 2,7-diaza-spiro[4.5]dec-7-yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
| BR112022022184A2 (pt) * | 2020-05-04 | 2023-01-17 | Takeda Pharmaceuticals Co | Derivados de n-(piperidin-4-il)benzamida agindo luminalmente |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH111472A (ja) | 1996-04-30 | 1999-01-06 | Dainippon Pharmaceut Co Ltd | ベンズアミド誘導体及びそれを含有する医薬組成物 |
| WO1999055674A1 (en) * | 1998-04-28 | 1999-11-04 | Dainippon Pharmaceutical Co., Ltd. | 1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| JP2000080081A (ja) | 1998-06-24 | 2000-03-21 | Dainippon Pharmaceut Co Ltd | １―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物 |
| JP2001122784A (ja) | 1999-10-27 | 2001-05-08 | Dainippon Pharmaceut Co Ltd | １−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬 |
-
2002
- 2002-12-18 US US10/321,615 patent/US6696468B2/en not_active Expired - Fee Related
-
2003
- 2003-01-03 DK DK03250050T patent/DK1362857T3/da active
- 2003-01-03 AT AT03250050T patent/ATE273304T1/de not_active IP Right Cessation
- 2003-01-03 DE DE60300021T patent/DE60300021T2/de not_active Expired - Fee Related
- 2003-01-03 ES ES03250050T patent/ES2227500T3/es not_active Expired - Lifetime
- 2003-01-03 PT PT03250050T patent/PT1362857E/pt unknown
- 2003-01-03 EP EP03250050A patent/EP1362857B1/de not_active Expired - Lifetime
- 2003-05-08 TW TW092112525A patent/TW200400186A/zh unknown
- 2003-05-15 KR KR10-2004-7018158A patent/KR20040107520A/ko not_active Withdrawn
- 2003-05-15 CZ CZ20041084A patent/CZ20041084A3/cs unknown
- 2003-05-15 TR TR2004/03020T patent/TR200403020T2/xx unknown
- 2003-05-15 IL IL16501203A patent/IL165012A0/xx unknown
- 2003-05-15 JP JP2003137413A patent/JP3643107B2/ja not_active Expired - Fee Related
- 2003-05-15 CN CNA03811089XA patent/CN1653063A/zh active Pending
- 2003-05-15 BR BR0309933-4A patent/BR0309933A/pt not_active Application Discontinuation
- 2003-05-15 MX MXPA04011332A patent/MXPA04011332A/es unknown
- 2003-05-15 CA CA002483368A patent/CA2483368A1/en not_active Abandoned
- 2003-05-15 WO PCT/JP2003/006051 patent/WO2003097638A1/en not_active Ceased
- 2003-05-15 PL PL03372724A patent/PL372724A1/xx not_active Application Discontinuation
- 2003-05-15 HU HU0501016A patent/HUP0501016A2/hu unknown
- 2003-05-15 AU AU2003230245A patent/AU2003230245A1/en not_active Abandoned
- 2003-05-15 RU RU2004136853/04A patent/RU2004136853A/ru not_active Application Discontinuation
- 2003-05-15 SK SK5019-2004A patent/SK50192004A3/sk unknown
- 2003-05-15 AR ARP030101702A patent/AR040021A1/es unknown
-
2004
- 2004-11-09 ZA ZA200409035A patent/ZA200409053B/en unknown
- 2004-12-15 NO NO20045469A patent/NO20045469L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6696468B2 (en) | 2004-02-24 |
| TW200400186A (en) | 2004-01-01 |
| US20030216433A1 (en) | 2003-11-20 |
| DE60300021D1 (de) | 2004-09-16 |
| AR040021A1 (es) | 2005-03-09 |
| EP1362857B1 (de) | 2004-08-11 |
| DE60300021T2 (de) | 2005-09-08 |
| PT1362857E (pt) | 2004-11-30 |
| RU2004136853A (ru) | 2005-06-27 |
| AU2003230245A1 (en) | 2003-12-02 |
| HUP0501016A2 (en) | 2006-02-28 |
| ZA200409053B (en) | 2005-07-12 |
| CA2483368A1 (en) | 2003-11-27 |
| TR200403020T2 (tr) | 2005-05-23 |
| DK1362857T3 (da) | 2004-12-20 |
| JP2004043453A (ja) | 2004-02-12 |
| CZ20041084A3 (cs) | 2005-02-16 |
| BR0309933A (pt) | 2005-02-09 |
| MXPA04011332A (es) | 2005-02-14 |
| ES2227500T3 (es) | 2005-04-01 |
| JP3643107B2 (ja) | 2005-04-27 |
| HK1060118A1 (en) | 2004-07-30 |
| CN1653063A (zh) | 2005-08-10 |
| IL165012A0 (en) | 2005-12-18 |
| EP1362857A1 (de) | 2003-11-19 |
| WO2003097638A1 (en) | 2003-11-27 |
| PL372724A1 (en) | 2005-07-25 |
| KR20040107520A (ko) | 2004-12-20 |
| NO20045469L (no) | 2005-02-16 |
| SK50192004A3 (sk) | 2005-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE273304T1 (de) | (s)-4-amino-5-chloro-2-methoxy-n-(1-(1-(2- tetrahydrofuryl-carbonyl)-4-piperidinylmethyl)- - piperidinyl)benzamid zur behandlung von magen- darmbewegungskrankheiten | |
| EP1622633A4 (de) | Behandlung von t-zell-vermittelten krankheiten | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| ATE350375T1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen | |
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE60335560D1 (de) | Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen | |
| DE60328476D1 (de) | Medizinisches ballonsystem zur behandlung von adipositas | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| DE60322582D1 (de) | Oberflächenbehandlung von medizinischem gerät | |
| ATE413385T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| ATE417037T1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| CY2016043I1 (el) | Μεθοδος για τη θεραπευτικη αγωγη της πολλαπλης σκληρυνσης | |
| DE60322451D1 (de) | 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung | |
| EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| EP1651237A4 (de) | Verfahren zur behandlung von dermatologischen erkrankungen | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| DE602004004262D1 (de) | Ultraschallbehandlung von gewebematrices | |
| DE60315490D1 (de) | Therapeutische behandlung | |
| NO20052814D0 (no) | Cytomodulerende peptider for behandling av interstitielle cystitt | |
| DE50308460D1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1362857 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |